Developer docs
API playgroundTry for free, no card

Search company profiles

Cohero Health

Full company profile

uuid00023ho

Namestring
Cohero Health
Legal namestring
COHERO Health Inc.
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Cohero Health is a New York-based private digital health company founded in 2013 that develops a connected health platform for patients with respiratory illness, primarily asthma and chronic obstructive pulmonary disease (COPD). The company's core product is a set of smart inhaler tracking sensors—branded as HeroTracker—that attach to metered dose and Diskus inhalers and capture medication usage, timing, and frequency, transmitting this data via Bluetooth to a software application used for medication adherence monitoring and remote patient management.

Underlying the hardware is a digital respiratory platform aggregating inhaler-usage data with patient-reported outcomes to support disease management for asthma and COPD populations. The company's value proposition centers on improving medication adherence, enabling remote monitoring of respiratory conditions, and providing data on inhaler usage patterns that is otherwise difficult to capture in clinical or home settings. Distribution and revenue mechanics are not publicly disclosed: pricing is not published, named enterprise customers are not disclosed, and the company operates with a headcount of 11–50 employees. Capital has been raised through a Series A led by Zaffre Investments (2015) and a Series B led by Three Leaf Ventures (2016), with strategic participation from Omron Healthcare, Samsung NEXT, BioAdvance, and several other funds, totaling approximately $16.8 million in disclosed equity funding across six rounds through 2017. Leadership is consolidated under CEO and Executive Chairman Joseph Condurso. Notably, the HeroTracker sensor brand currently appears within Aptar Digital Health's connected drug delivery product portfolio, indicating the technology has been incorporated into a global pharma packaging platform's offerings.

Short descriptiontext

Cohero Health is a New York-based private digital health company, founded in 2013, that develops connected smart inhaler sensors and a respiratory health platform for medication adherence and remote monitoring of asthma and COPD patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
connected inhaler sensors, respiratory disease management, smart inhaler tracking, digital asthma monitoring, COPD remote monitoring
Industry3 codes
1Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps)
CodeHLAHAIAMPrimaryYes
2Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories)
CodeHLAHAGAEPrimaryNo
3Asthma & Allergy-Related Pulmonary Care
CodeHLAKANADPrimaryNo
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Digital Respiratory Health
Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Cohero Health builds a connected respiratory health platform centered on proprietary Bluetooth-enabled smart inhaler sensors (HeroTracker) and a Bluetooth-enabled lung function sensor (MSpirometer) that capture medication usage, timing, frequency, and spirometry data for asthma and COPD patients. The hardware feeds a respiratory disease management software platform that aggregates adherence, lung function, symptom, and trigger data into a single mobile app for patients and their care teams. The platform also includes the Allergy Buddy companion app for allergic rhinitis and seasonal allergy self-management.

Differentiator
Functional benefit
Problem solved
Product and service4 records
1HeroTracker Inhaler Sensors
CategoryConnected Medical Devices
Description

Bluetooth-enabled medication inhaler tracker sensors compatible with most MDI and Diskus inhalers, designed to capture medication usage, timing, and frequency for patients with asthma and COPD. The sensors feed adherence data into Cohero Health's connected respiratory disease management platform for use by patients, clinicians, and care teams.

2MSpirometer Lung Function Sensor
CategoryConnected Medical Devices
Description

A Bluetooth-enabled connected spirometry device that measures peak flow, FEV1, FVC, and other key pulmonary metrics as a connected add-on for pressurized Metered Dose Inhalers, enabling remote lung function assessment for respiratory disease management.

3Respiratory Disease Management Platform
CategoryDigital Health Platform
Description

An end-to-end mobile software platform that aggregates all respiratory data flows — adherence monitoring, lung function assessment, symptom reporting, and trigger identification — into a single smartphone app for asthma and COPD patients, with patient access to educational resources, training content, and direct communication channels with their care team and health coaches.

4Allergy Buddy Mobile App
CategoryDigital Health Platform
Description

A proactive, user-centric companion mobile app for people living with allergic rhinitis and seasonal allergies that blends real-time local weather and air quality data with quick, easy check-ins to deliver clear guidance, supporting self-management between clinical visits.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

European smart inhaler add-on sensor company focused on asthma and COPD medication adherence. Comparable product concept to Cohero but serving primarily European markets.

TypeDirect peer
Description

A division of Aptar Pharma offering 'HeroTracker' Bluetooth-enabled inhaler sensors and an end-to-end respiratory management platform with companion apps. Direct competitor to Cohero in connected inhaler technology, with a much broader portfolio including an MSpirometer lung function sensor.

TypeDirect peer
Description

Pioneer in connected inhaler sensors for asthma and COPD management; acquired by ResMed in 2019. Closely comparable product offering (smart inhaler sensors + adherence platform) and the most established player in Cohero's exact category.

TypeDirect peer
Description

Smart inhaler sensor company focused on medication adherence for asthma and COPD; offers the Hailie sensor compatible with multiple inhaler types. Directly comparable technology and target end-market to Cohero.

TypeBroad incumbent
Description

Launched the Digihaler line of FDA-cleared connected inhalers with built-in sensors for asthma/COPD. A vertically integrated pharma player that competes with Cohero by embedding smart-inhaler capability directly into branded drug-device combinations.

TypeBroad incumbent
Description

Global respiratory and sleep therapy leader; acquired Propeller Health to add connected inhaler capabilities to its sleep apnea and COPD portfolio. A scaled incumbent that competes with Cohero in respiratory digital health.

TypeBroad incumbent
Description

Major respiratory pharma player (Symbicort, Breztri, Fasenra) that has invested in connected inhaler pilots and partnerships. Competes indirectly by integrating digital adherence features into its inhaled therapeutics franchises.

TypeBroad incumbent
Description

Global pharma leader in respiratory (Trelegy, Nucala, Advair) actively exploring connected inhaler and adherence partnerships. A potential pharma partner or competitor to Cohero in the connected asthma/COPD space.

TypeEmerging player
Description

Digital health company focused on remote patient monitoring for chronic conditions including COPD. Overlaps with Cohero in respiratory remote monitoring, though with a broader platform approach rather than inhaler sensors specifically.

TypeEmerging player
Description

Digital health company offering connected respiratory devices (including spirometry) and remote monitoring for COPD and asthma patients. Comparable in scope of connected respiratory hardware + software for the same patient population.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors15 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cohero Health

Digital Respiratory Healthcoherohealth.com

Cohero Health is a New York-based private digital health company, founded in 2013, that develops connected smart inhaler sensors and a respiratory health platform for medication adherence and remote monitoring of asthma and COPD patients.

What Cohero Health does

Cohero Health is a New York-based private digital health company founded in 2013 that develops a connected health platform for patients with respiratory illness, primarily asthma and chronic obstructive pulmonary disease (COPD). The company's core product is a set of smart inhaler tracking sensors—branded as HeroTracker—that attach to metered dose and Diskus inhalers and capture medication usage, timing, and frequency, transmitting this data via Bluetooth to a software application used for medication adherence monitoring and remote patient management.

Underlying the hardware is a digital respiratory platform aggregating inhaler-usage data with patient-reported outcomes to support disease management for asthma and COPD populations. The company's value proposition centers on improving medication adherence, enabling remote monitoring of respiratory conditions, and providing data on inhaler usage patterns that is otherwise difficult to capture in clinical or home settings. Distribution and revenue mechanics are not publicly disclosed: pricing is not published, named enterprise customers are not disclosed, and the company operates with a headcount of 11–50 employees. Capital has been raised through a Series A led by Zaffre Investments (2015) and a Series B led by Three Leaf Ventures (2016), with strategic participation from Omron Healthcare, Samsung NEXT, BioAdvance, and several other funds, totaling approximately $16.8 million in disclosed equity funding across six rounds through 2017. Leadership is consolidated under CEO and Executive Chairman Joseph Condurso. Notably, the HeroTracker sensor brand currently appears within Aptar Digital Health's connected drug delivery product portfolio, indicating the technology has been incorporated into a global pharma packaging platform's offerings.

Cohero Health firmographics

Firmographics
Name
Cohero Health
Legal name
COHERO Health Inc.
Website
https://coherohealth.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Cohero Health is a New York-based private digital health company, founded in 2013, that develops connected smart inhaler sensors and a respiratory health platform for medication adherence and remote monitoring of asthma and COPD patients.
Ownership category
akta.pro rank

Cohero Health industry classification

Industry
Product category
Digital Respiratory Health
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro primary industry
Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps) (HLAHAIAM)
akta.pro secondary industries
Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories) (HLAHAGAE), Asthma & Allergy-Related Pulmonary Care (HLAKANAD)

Keywords

  • Connected inhaler sensors
  • Respiratory disease management
  • Smart inhaler tracking
  • Digital asthma monitoring
  • COPD remote monitoring

Where Cohero Health is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Markets served

Cohero Health business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Cohero Health product offering

Product offering

Core offering

Cohero Health builds a connected respiratory health platform centered on proprietary Bluetooth-enabled smart inhaler sensors (HeroTracker) and a Bluetooth-enabled lung function sensor (MSpirometer) that capture medication usage, timing, frequency, and spirometry data for asthma and COPD patients. The hardware feeds a respiratory disease management software platform that aggregates adherence, lung function, symptom, and trigger data into a single mobile app for patients and their care teams. The platform also includes the Allergy Buddy companion app for allergic rhinitis and seasonal allergy self-management.

Differentiator

Problem solved

Functional benefit

Products and services

  • HeroTracker Inhaler Sensors Bluetooth-enabled medication inhaler tracker sensors compatible with most MDI and Diskus inhalers, designed to capture medication usage, timing, and frequency for patients with asthma and COPD. The sensors feed adherence data into Cohero Health's connected respiratory disease management platform for use by patients, clinicians, and care teams.
  • MSpirometer Lung Function Sensor A Bluetooth-enabled connected spirometry device that measures peak flow, FEV1, FVC, and other key pulmonary metrics as a connected add-on for pressurized Metered Dose Inhalers, enabling remote lung function assessment for respiratory disease management.
  • Respiratory Disease Management Platform An end-to-end mobile software platform that aggregates all respiratory data flows — adherence monitoring, lung function assessment, symptom reporting, and trigger identification — into a single smartphone app for asthma and COPD patients, with patient access to educational resources, training content, and direct communication channels with their care team and health coaches.
  • Allergy Buddy Mobile App A proactive, user-centric companion mobile app for people living with allergic rhinitis and seasonal allergies that blends real-time local weather and air quality data with quick, easy check-ins to deliver clear guidance, supporting self-management between clinical visits.

Companies that use Cohero Health

Customer profile

Segments1 record

Ideal customer profiles3 records

Cohero Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Cohero Health partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Cohero Health competitors and assessment

Company assessment

Emerging players

  • FindAir: European smart inhaler add-on sensor company focused on asthma and COPD medication adherence. Comparable product concept to Cohero but serving primarily European markets.
  • HGE Health: Digital health company focused on remote patient monitoring for chronic conditions including COPD. Overlaps with Cohero in respiratory remote monitoring, though with a broader platform approach rather than inhaler sensors specifically.
  • Wellinks: Digital health company offering connected respiratory devices (including spirometry) and remote monitoring for COPD and asthma patients. Comparable in scope of connected respiratory hardware + software for the same patient population.

Direct peers

  • Aptar Digital Health: A division of Aptar Pharma offering 'HeroTracker' Bluetooth-enabled inhaler sensors and an end-to-end respiratory management platform with companion apps. Direct competitor to Cohero in connected inhaler technology, with a much broader portfolio including an MSpirometer lung function sensor.
  • Propeller Health: Pioneer in connected inhaler sensors for asthma and COPD management; acquired by ResMed in 2019. Closely comparable product offering (smart inhaler sensors + adherence platform) and the most established player in Cohero's exact category.
  • Adherium: Smart inhaler sensor company focused on medication adherence for asthma and COPD; offers the Hailie sensor compatible with multiple inhaler types. Directly comparable technology and target end-market to Cohero.

Broad incumbents

  • Teva Pharmaceutical Industries: Launched the Digihaler line of FDA-cleared connected inhalers with built-in sensors for asthma/COPD. A vertically integrated pharma player that competes with Cohero by embedding smart-inhaler capability directly into branded drug-device combinations.
  • ResMed: Global respiratory and sleep therapy leader; acquired Propeller Health to add connected inhaler capabilities to its sleep apnea and COPD portfolio. A scaled incumbent that competes with Cohero in respiratory digital health.
  • AstraZeneca: Major respiratory pharma player (Symbicort, Breztri, Fasenra) that has invested in connected inhaler pilots and partnerships. Competes indirectly by integrating digital adherence features into its inhaled therapeutics franchises.
  • GSK: Global pharma leader in respiratory (Trelegy, Nucala, Advair) actively exploring connected inhaler and adherence partnerships. A potential pharma partner or competitor to Cohero in the connected asthma/COPD space.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Cohero Health social profiles

Digital presence

Cohero Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cohero Health leadership team

Management profile

Number of profiles

Profiles2 records

Cohero Health funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors15 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cohero Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cohero Health

What does Cohero Health do?

Cohero Health builds a connected respiratory health platform centered on proprietary Bluetooth-enabled smart inhaler sensors (HeroTracker) and a Bluetooth-enabled lung function sensor (MSpirometer) that capture medication usage, timing, frequency, and spirometry data for asthma and COPD patients. The hardware feeds a respiratory disease management software platform that aggregates adherence, lung function, symptom, and trigger data into a single mobile app for patients and their care teams. The platform also includes the Allergy Buddy companion app for allergic rhinitis and seasonal allergy self-management.

Is Cohero Health a public or private company?

Cohero Health is a private company. It is classified as corporate owned and is currently operating.

When was Cohero Health founded?

Cohero Health was founded in 2013. It employs 11 to 50 people.

Where is Cohero Health based?

Cohero Health is headquartered in New York, United States, in the North America region.

Who are Cohero Health's main competitors?

Emerging players on record are FindAir, HGE Health and Wellinks. Direct peers are Aptar Digital Health, Propeller Health and Adherium. Broad incumbents are Teva Pharmaceutical Industries, ResMed, AstraZeneca and GSK.

Does Cohero Health have an API?

No public API is recorded for Cohero Health.

What industry is Cohero Health in?

Cohero Health's product category is Digital Respiratory Health. Its primary akta.pro industry code is HLAHAIAM, Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps), with a secondary code of HLAHAGAE, Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories). Its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Fact.MRDigital Respiratory Devices Market Size & Statistics 2035Fact.MR published a comprehensive market research report projecting the global digital respiratory devices market to grow from USD 10.7 billion in 2024 to USD 121 billion by 2035, representing a 10.2x expansion over the forecast period with a CAGR of 26.1%. The report identifies key growth drivers including rising respiratory disease prevalence (asthma, COPD), technological advancements in smart inhalers and IoT-connected devices, and increasing adoption of telemedicine and remote patient monitoring. Key players profiled include COHERO Health Inc., Cognita Labs, Adherium Limited, Teva Pharmaceuticals Industries Ltd., and Propeller Health, while North America currently leads the market and Asia-Pacific represents the fastest-growing region.VC News DailyCohero Health Adds to Series ACohero Health, a digital health company based in New York City, announced the addition of Samsung NEXT and Omron Healthcare as strategic investors to its previously announced $9 million Series A round, oversubscribing the financing. The supplemental funds will be used to expand BreatheSmart, the company's respiratory disease management platform, and support broader commercialization of its pulmonary care hardware and software. The investment from these leading technology companies is expected to accelerate product development and enable collaboration on new respiratory care products and services.FinSMEsCohero Health Receives Additional Investment from Samsung NEXT and Omron HealthcareCohero Health closed its Series A financing with Samsung NEXT and Omron Healthcare as investors, adding to a previously announced $9M round. The investments will support commercialization of BreatheSmart and product development. The company provides respiratory disease management tools via smart mobile devices.VC News DailyCohero Health Closes $9M Series A FundingCohero Health, a digital health company focused on respiratory care, has closed a $9 million Series A funding round led by Three Leaf Ventures with participation from Zaffre Investments, BioAdvance, GIS Strategic Ventures, Heitkamp & Thumann Group, and P5 Health Ventures. The funds will be used to grow commercial business development, expand clinical trials, and evolve the company's BreatheSmart connected platform for tracking medication adherence and measuring lung function in asthma, COPD, and cystic fibrosis patients. The company has already deployed its platform across more than 25 commercial partnerships representing over 1 million patients.Respiratory TherapyPartnership Seeks to Improve Medication Adherence for Asthma, COPD PatientsCohero Health and ProCare Rx are partnering to integrate their health platforms to improve medication adherence among respiratory patients. The collaboration aims to enhance patient outcomes and reduce healthcare costs by combining device-based monitoring with medication management services.FinSMEsCohero Health Closes $2M Seed Funding RoundCohero Health, a New York-based digital health company, closed a $2M seed funding round from Zaffre Investments, Three Leaf Ventures, Swanhill Capital, and StartUp Health. The funds will scale production of its devices and support the full-scale commercial launch of its platform, which includes wireless inhaler sensors and an FDA-cleared mobile spirometer.VC News DailyCohero Health Secures $2M Seed InvestmentCohero Health, a New York-based digital health company focused on respiratory care, has closed a $2 million seed investment round led by Zaffre Investments, Three Leaf Ventures, Bioadvance, Swanhill Capital, and StartUp Health. The company's platform combines wireless medication inhaler sensors and FDA-cleared mobile spirometers to help asthma and COPD patients track lung function and medication adherence, with early deployments at Mount Sinai Health System and Dartmouth-Hitchcock Medical Center showing a 2.5 times increase in medication adherence and zero hospitalizations. The company plans to use the funding to scale production and support full commercial launch.TechCrunchCohero Health Aims To Improve Patient Care For The 26 Million American Asthma SufferersCohero Health launched its connected health platform for asthma patients at TechCrunch Disrupt San Francisco 2015, featuring the HeroTracker inhaler sensor and a mobile spirometer. The company received FDA clearance for its spirometer in June and operates on a B2B subscription model targeting pharmaceutical companies, insurers, and clinics to improve patient adherence and reduce hospitalizations.